These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19203725)

  • 1. The contribution of malglycemia to mortality among allogeneic hematopoietic cell transplant recipients.
    Hammer MJ; Casper C; Gooley TA; O'Donnell PV; Boeckh M; Hirsch IB
    Biol Blood Marrow Transplant; 2009 Mar; 15(3):344-51. PubMed ID: 19203725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Association between Blood Glucose Levels and Nonrelapse Mortality after Allogeneic Hematopoietic Cell Transplantation Based on Presence or Absence of Preexisting Diabetes.
    Rashid N; Gooley T; Boeckh M; Oshima MU; Chao JH; Hirsch IB; Mielcarek M
    Transplant Cell Ther; 2024 Apr; 30(4):417.e1-417.e9. PubMed ID: 38242443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malglycemia is associated with poor outcomes in pediatric and adolescent hematopoietic stem cell transplant patients.
    Sopfe J; Pyle L; Keating AK; Campbell K; Liu AK; Wadwa RP; Verneris MR; Giller RH; Forlenza GP
    Blood Adv; 2019 Feb; 3(3):350-359. PubMed ID: 30718242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycemic Status and Infection Risk in Nondiabetic Autologous Hematopoietic Cell Transplantation Recipients.
    Hammer MJ; D'Eramo Melkus G; Knobf MT; Casper C; Fletcher J; Cleland CM
    Biol Res Nurs; 2016 May; 18(3):344-50. PubMed ID: 26792914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood glucose control using a computer-guided glucose management system in allogeneic hematopoietic cell transplant recipients.
    Espina C; Jenkins I; Taylor L; Farah R; Cho E; Epworth J; Coleman K; Pinelli J; Mentzer S; Jarrett L; Gooley T; O'Donnell P; Hirsch IB; Bar M
    Bone Marrow Transplant; 2016 Jul; 51(7):973-9. PubMed ID: 27042836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic Cell Transplantation-Specific Comorbidity Index Predicts Morbidity and Mortality in Autologous Stem Cell Transplantation.
    Berro M; Arbelbide JA; Rivas MM; Basquiera AL; Ferini G; Vitriu A; Foncuberta C; Fernandez Escobar N; Requejo A; Milovic V; Yantorno S; Szelagoswki M; Martinez Rolon J; Bentolila G; Garcia JJ; Garcia P; Caeiro G; Castro M; Jaimovich G; Palmer S; Trucco JI; Bet LA; Shaw BE; Kusminsky GD
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1646-1650. PubMed ID: 28669923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysglycemia following glucocorticoid therapy for acute graft-versus-host disease adversely affects transplantation outcomes.
    Pidala J; Kim J; Kharfan-Dabaja MA; Nishihori T; Field T; Perkins J; Perez L; Fernandez H; Anasetti C
    Biol Blood Marrow Transplant; 2011 Feb; 17(2):239-48. PubMed ID: 20637884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malglycemia in the critical care setting. Part III: Temporal patterns, relative potencies, and hospital mortality.
    Roberts GW; Krinsley JS; Preiser JC; Quinn S; Rule PR; Brownlee M; Umpierrez GE; Hirsch IB
    J Crit Care; 2024 Jun; 81():154537. PubMed ID: 38364665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic implications of hematopoietic cell transplantation-specific comorbidity index on non-relapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation].
    Wang CY; Ren HY; Qiu ZX; Wang Y; Cen XN; Wang LH; Wang MJ; Xu WL; Wang WS; Li Y; Dong YJ; Ou JP; Liang ZY; Liu W; Wang Q
    Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):659-63. PubMed ID: 23978015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoalbuminemia at Day +90 Is Associated with Inferior Nonrelapse Mortality and Overall Survival in Allogeneic Hematopoietic Cell Transplantation Recipients: A Confirmatory Study.
    Murthy HS; Sheets K; Kumar A; Nishihori T; Mina A; Chavez JC; Ayala E; Field T; Mathews J; Locke F; Perez L; Betts BC; Khimani F; Miladinovic B; Tsalatsanis A; Ochoa-Bayona JL; Alsina M; Fernandez H; Pidala J; Anasetti C; Kharfan-Dabaja MA
    Biol Blood Marrow Transplant; 2018 Feb; 24(2):400-405. PubMed ID: 29032266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycemic variability is associated with poor outcomes in pediatric hematopoietic stem cell transplant patients.
    Sopfe J; Campbell K; Keating AK; Pyle L; Liu AK; Verneris MR; Giller RH; Forlenza GP
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28626. PubMed ID: 33480469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary Impairment after Respiratory Viral Infections Is Associated with High Mortality in Allogeneic Hematopoietic Cell Transplant Recipients.
    Sheshadri A; Chemaly RF; Alousi AM; Shah PK; Rondon G; Bashoura L; Kmeid J; Azzi J; Blanco DW; Kaous M; Dickey BF; Champlin RE; Shah DP
    Biol Blood Marrow Transplant; 2019 Apr; 25(4):800-809. PubMed ID: 30521974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malglycemia in the critical care setting. Part I: Defining hyperglycemia in the critical care setting using the glycemic ratio.
    Roberts G; Krinsley JS; Preiser JC; Quinn S; Rule PR; Brownlee M; Umpierrez GE; Hirsch IB
    J Crit Care; 2023 Oct; 77():154327. PubMed ID: 37178493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance status, but not the hematopoietic cell transplantation comorbidity index (HCT-CI), predicts mortality at a Canadian transplant center.
    Guilfoyle R; Demers A; Bredeson C; Richardson E; Rubinger M; Szwajcer D; Seftel MD
    Bone Marrow Transplant; 2009 Jan; 43(2):133-9. PubMed ID: 18762762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-transplant ferritin level predicts outcomes after allogeneic hematopoietic stem cell transplant, independent from pre-transplant ferritin level.
    Fingrut W; Law A; Lam W; Michelis FV; Viswabandya A; Lipton JH; Kumar R; Mattsson J; Kim DDH
    Ann Hematol; 2021 Mar; 100(3):789-798. PubMed ID: 33415423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Fluid Overload Is Associated with an Increased Risk of Nonrelapse Mortality after Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation.
    Rondon-Clavo C; Scordo M; Hilden P; Shah GL; Cho C; Maloy MA; Papadopoulos EB; Jakubowski AA; O'Reilly RJ; Gyurkocza B; Castro-Malaspina H; Tamari R; Shaffer BC; Perales MA; Jaimes EA; Giralt SA
    Biol Blood Marrow Transplant; 2018 Dec; 24(12):2517-2522. PubMed ID: 30055353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline Renal Function and Albumin are Powerful Predictors for Allogeneic Transplantation-Related Mortality.
    Shouval R; de Jong CN; Fein J; Broers AEC; Danylesko I; Shimoni A; Reurs MR; Baars AE; van der Schaft N; Nagler A; Cornelissen JJ
    Biol Blood Marrow Transplant; 2018 Aug; 24(8):1685-1691. PubMed ID: 29753163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social Vulnerability and Risk of Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation.
    Bhandari R; Teh JB; He T; Nakamura R; Artz AS; Jankowska MM; Forman SJ; Wong FL; Armenian SH
    J Natl Cancer Inst; 2022 Nov; 114(11):1484-1491. PubMed ID: 35980163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut off points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI Is the best predictor of NRM and OS in a population of patients undergoing allo-RIC.
    Barba P; Piñana JL; Martino R; Valcárcel D; Amorós A; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
    Biol Blood Marrow Transplant; 2010 Mar; 16(3):413-20. PubMed ID: 19922807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Performance of the Augmented Hematopoietic Cell Transplantation-Specific Comorbidity/Age Index in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation from Alternative Graft Sources.
    Elsawy M; Storer BE; Milano F; Sandmaier BM; Delaney C; Salit RB; Rashad AH; Woolfrey AE; Appelbaum FR; Storb R; Sorror ML
    Biol Blood Marrow Transplant; 2019 May; 25(5):1045-1052. PubMed ID: 30500442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.